MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CGEM has $402,984K in assets. $36,812K in debts. $75,081K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1028.07%
Quick Ratio
1028.07%
Cash Ratio
213.58%
Debt to Asset Ratio
9.13%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Long-term investments
    • Others
Liabilities Breakdown
    • Total stockholders' equity
    • Accrued expenses and other curre...
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
75,081 88,332 103,335 72,820
Short-term investments
276,804 289,564 229,261 192,662
Prepaid expenses and other current assets
9,522 8,860 9,639 10,429
Total current assets
361,407 386,756 342,235 275,911
Total property and equipment, gross
-1,390 --
Less accumulated depreciation
-969 --
Property and equipment, net
342 421 489 569
Operating lease right-of-use assets
2,437 2,630 1,046 1,180
Other assets
297 297 361 367
Long-term investments
38,501 58,270 139,995 242,302
Total assets
402,984 448,374 484,126 520,329
Accounts payable
2,509 841 1,722 2,461
Accrued expenses and other current liabilities
31,920 36,120 29,847 24,203
Operating lease liabilities, current
725 780 1,188 1,394
Total current liabilities
35,154 37,741 32,757 28,058
Operating lease liabilities, net of current portion
1,658 1,903 0 125
Total liabilities
36,812 39,644 32,757 28,183
Common stock, 0.0001 par value, 150,000,000 shares authorized as of december 31, 2025 and 2024 60,244,136 and 58,510,610 shares issued and outstanding as of december 31, 2025 and 2024, respectively
-6 6 6
Additional paid-in capital
-995,823 987,796 978,329
Accumulated other comprehensive gain (loss)
-1,020 973 607
Accumulated deficit
--588,119 -537,406 -486,796
Total cullinan stockholders' equity
-408,730 451,369 492,146
Noncontrolling interests
-0 0 0
Total stockholders' equity
366,172 408,730 451,369 492,146
Total liabilities and stockholders' equity
402,984 448,374 484,126 520,329
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$276,804K Cash and cashequivalents$75,081K Prepaid expenses andother current assets$9,522K Total current assets$361,407K Long-term investments$38,501K Operating leaseright-of-use assets$2,437K Property and equipment,net$342K Other assets$297K Total assets$402,984K Total liabilities andstockholders' equity$402,984K Total stockholders'equity$366,172K Total liabilities$36,812K Total currentliabilities$35,154K Operating leaseliabilities, net of current...$1,658K Accrued expenses andother current...$31,920K Accounts payable$2,509K Operating leaseliabilities, current$725K

Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics, Inc. (CGEM)